A novel SRD5A2 mutation in an Iranian family with sex development disorder

被引:1
|
作者
Hashemi-Gorji, Feyzollah [1 ]
Salehpour, Shadab [2 ]
Miryounesi, Mohammad [1 ]
Mirfakhraie, Reza [1 ,3 ]
Yassaee, Vahid Reza [1 ,3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Genom Res Ctr, Tehran 1985717413, Iran
[2] Shahid Beheshti Univ Med Sci, Dept Pediat, Fac Med, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Med Genet, Fac Med, Tehran, Iran
关键词
5‐ alpha‐ reductase‐ 2; gene; disorders of sex development; whole exome sequencing; CONSENSUS STATEMENT; DEVELOPMENT DSD; MANAGEMENT; GENOME; DEFICIENCY; DIAGNOSIS; ETIOLOGY; GENETICS;
D O I
10.1111/and.13847
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Disorders of sex development (DSD) are different types of conditions that their accurate diagnosis by using conventional phenotypic and biochemical approaches is a challenging issue. Precise determination of DSD is critical due to the detection of possible life-threatening associated disorders. It may also assist parents in choosing the most suitable management for their affected child. In this study, two affected kids born from consanguineous families who were clinically diagnosed for sex development disorder were investigated for the main cause of the disease. Biochemical analysis failed to make an accurate diagnosis. Karyotype analysis showed an abnormal sex chromosome pattern. Whole exome sequencing was sequentially applied to precisely ascertain the genetic cause of the disease. A novel deletion, g.40936_53878del12943insTG (NG_008365.1), and one known mutation, c.586G>A (p.Gly196Ser), were detected in SRD5A2 gene in case I and case II respectively. Further analysis was performed using polymerase chain reaction, primer walking and Sanger sequencing to detect the nucleotides changes accurately. Segregation analysis in the families confirmed 13kb novel homozygous deletion of SRD5A2 in case I and c.586G>A in case II. The present study confirms the diagnostic value of whole exome sequencing in the detection of DSD aetiology, especially when several differential diagnoses are possible.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Spectrum of Pathogenic Variants in SRD5A2 in Indian Children with 46,XY Disorders of Sex Development and Clinically Suspected Steroid 5α-Reductase 2 Deficiency
    Kumar, Anil
    Sharma, Rajni
    Faruq, Mohammed
    Suroliya, Varun
    Kumar, Manoj
    Sharma, Shilpa
    Werner, Ralf
    Hiort, Olaf
    Jain, Vandana
    SEXUAL DEVELOPMENT, 2020, 13 (5-6) : 228 - 239
  • [32] Identification and functional characterization of two novel SRD5A2 variants in Iranian siblings with 5α-reductase type 2 deficiency: Expanding the mutational spectrum and implications for genetic diagnosis
    Ordooei, Mahtab
    Zamani, Nasrin
    Rabbani, Bahareh
    Mahdieh, Nejat
    HUMAN GENE, 2025, 43
  • [33] A polymorphism in 5-alpha-reductase (SRD5A2) gene shows novel association with prostate cancer
    Minarik, M.
    Benesova, L.
    Fantova, L.
    Heracek, J.
    Urban, M.
    Loukola, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 49 - 49
  • [34] Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias
    Wang, Ruifang
    Dong, Zhiya
    Wang, Wei
    Xiao, Yuan
    Ni, Jihong
    Wang, Defen
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (9-10): : 887 - 893
  • [35] The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency
    Skordis, N.
    Neocleous, V.
    Kyriakou, A.
    Efstathiou, E.
    Sertedaki, A.
    Philibert, P.
    Phylactou, L. A.
    Lumbroso, S.
    Sultan, C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (11) : 810 - 814
  • [36] 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation
    Schiffer, Lina
    Arlt, Wiebke
    Storbeck, Karl -Heinz
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 241
  • [37] The IVS1- 2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency
    N. Skordis
    V. Neocleous
    A. Kyriakou
    E. Efstathiou
    A. Sertedaki
    P. Philibert
    L. A. Phylactou
    S. Lumbroso
    C. Sultan
    Journal of Endocrinological Investigation, 2010, 33 : 810 - 814
  • [38] SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL
    Al-Faouri, Ra'ad
    Sharkey, Christina
    Wang, Zongwei
    Olumi, Aria F.
    JOURNAL OF UROLOGY, 2023, 209 : E70 - E71
  • [39] Association of SRD5A2 genotype and pathological characteristics of prostate tumors
    Jaffe, JM
    Malkowicz, SB
    Walker, AH
    MacBride, S
    Peschel, R
    Tomaszewski, J
    Van Arsdalen, K
    Wein, AJ
    Rebbeck, TR
    CANCER RESEARCH, 2000, 60 (06) : 1626 - 1630
  • [40] SRD5A2 gene polymorphisms affect the risk of breast cancer
    Francis, Amirtharaj
    Sarkar, Saumya
    Pooja, Singh
    Surekha, Daminani
    Rao, Digumarthi Raghunatha
    Rao, Lakshmi
    Ramachandra, Lingadakai
    Vishnupriya, Satti
    Satyamoorthy, Kapaettu
    Thangaraj, Kumarasamy
    Rajender, Singh
    BREAST, 2014, 23 (02): : 137 - 141